Molecular architecture of the Cryptococcus neoformans capsule
- 13 February 2004
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 52 (1), 13-24
- https://doi.org/10.1111/j.1365-2958.2003.03957.x
Abstract
Many microbes are surrounded by phagocytosis‐inhibiting capsules. We took advantage of the large size of the polysaccharide capsule of the pathogenic yeast Cryptococcus neoformans to examine capsular architecture and the relationship between molecular architecture and the interaction of the capsule with potentially opsonic serum proteins. Our experimental design used complementary approaches in which (i) assessment of permeability to macromolecules of different Stokes radii; (ii) determination of the binding of Fab fragments of anticapsular antibodies as a measure of matrix density; (iii) capsular deconstruction by treatment with dimethyl sulphoxide; and (iv) evaluation of capsule plasticity, were used to probe the molecular structure of the capsule. The results showed that the capsule is a matrix with a variable porosity that increases with distance from the cell wall. A high density of the matrix at the capsule interior prevents penetration of large macromolecules to sites near the cell wall. In contrast, the capsular edge that is the interface with phagocytes presents capsular polysaccharide in a very low density that exhibits considerable plasticity and permeability to macromolecules. Notably, the capsule of yeast cells harvested from infected tissue showed a greater matrix density than yeast cells grown in vitro under capsule induction conditions.Keywords
This publication has 38 references indexed in Scilit:
- The efficacy of complement‐mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3‐mediated interactionsEuropean Journal of Immunology, 2003
- Antigenic and Biological Characteristics of Mutant Strains ofCryptococcus neoformansLacking Capsular O Acetylation or Xylosyl Side ChainsInfection and Immunity, 2003
- Contribution of Epitope Specificity to the Binding of Monoclonal Antibodies to the Capsule of Cryptococcus neoformans and the Soluble Form of Its Major Polysaccharide, GlucuronoxylomannanClinical and Vaccine Immunology, 2003
- Fc-Dependent and Fc-Independent Opsonization of Cryptococcus neoformans by Anticapsular Monoclonal Antibodies: Importance of Epitope SpecificityInfection and Immunity, 2002
- In Vivo Clearance of Glucuronoxylomannan, the Major Capsular Polysaccharide ofCryptococcus neoformans:A Critical Role for Tissue MacrophagesThe Journal of Infectious Diseases, 2001
- Molecular mobility and nucleocytoplasmic flux in hepatoma cells.The Journal of cell biology, 1986
- Capsular Polysaccharides of Cryptococcus neoformansClinical Infectious Diseases, 1984
- Natural Host Resistance to Infection with Cryptococcus Neoformans: III. The Effect of Cryptococcal Polysaccharide upon the Physiology of the Reticuloendothelial System of Laboratory AnimalsThe Journal of Infectious Diseases, 1964
- Restricted diffusion of macromolecules through agar-gel membranesBiochimica et Biophysica Acta, 1962